NEW YORK (WKZO) — Drugmaker Pfizer is buying Hospira for just over 15-billion dollars. Pfizer said the deal is a good fit with its “global established pharmaceutical business” and would create significant shareholder value. Hospira is a big maker of injectable drugs, a booming market that’s expected to reach 70-billion dollars in five years.
Pfizer buying Hospira for 15-billion dollars
Feb 5, 2015 | 6:18 PM
